疫苗犹豫:社区药房超越二元疫苗接种结果的实践

IF 1.6 Q3 PHARMACOLOGY & PHARMACY Canadian Pharmacists Journal Pub Date : 2019-10-09 DOI:10.1177/1715163519878745
Richard Violette, G. R. Pullagura
{"title":"疫苗犹豫:社区药房超越二元疫苗接种结果的实践","authors":"Richard Violette, G. R. Pullagura","doi":"10.1177/1715163519878745","DOIUrl":null,"url":null,"abstract":"Introduction Unequivocally, vaccinations can be considered one of the greatest global achievements for public health. Since the introduction of the first vaccines, vaccination programs have contributed to a substantial decline in both mortality and morbidity of many previously lethal infectious diseases around the globe. However, high and sustained vaccine uptake is necessary for these efforts to remain successful. Beyond the direct protection provided for vaccinated individuals, high vaccine coverage also induces indirect protection against vaccinepreventable diseases (VPD) at a population level through herd immunity. Yet despite consensus on the public health benefits of vaccination, recent reports of clustered outbreaks and the resurgence of VPDs in underor nonimmunized groups highlight the ongoing challenges. The concept of vaccine hesitancy represents a significant conceptual shift away from the traditional dichotomy of accept or reject, of proor antivaccine. Defined by the World Health Organization’s (WHO) SAGE Working Group as “the delay in acceptance or refusal of vaccination despite availability of vaccination services,” vaccine hesitancy is “complex and context specific, varying across time, place and vaccines. It is influenced by factors such as complacency, convenience and confidence.” Vaccine hesitancy highlights the wide spectrum of vaccination beliefs, attitudes and behaviours of a large heterogeneous group of individuals situated between the 2 end points of the continuum (see Figure 1). For example, vaccine-hesitant individuals may refuse some vaccines but accept or delay others; some may accept a vaccine but remain concerned with their decision; and others may even personally refuse all vaccines but remain supportive of vaccinations more broadly. While vaccine hesitancy is not always the root cause of underor nonimmunization, it is listed in the top 10 threats to global health for 2019 by the WHO and remains an important contributor to suboptimal vaccine coverage across many jurisdictions. A large body of interdisciplinary research has explored the factors and determinants that shape vaccine-hesitant beliefs, attitudes and behaviours. From a practice perspective, 3 observations are particularly important:","PeriodicalId":46612,"journal":{"name":"Canadian Pharmacists Journal","volume":"152 1","pages":"391 - 394"},"PeriodicalIF":1.6000,"publicationDate":"2019-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1715163519878745","citationCount":"8","resultStr":"{\"title\":\"Vaccine hesitancy: Moving practice beyond binary vaccination outcomes in community pharmacy\",\"authors\":\"Richard Violette, G. R. Pullagura\",\"doi\":\"10.1177/1715163519878745\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction Unequivocally, vaccinations can be considered one of the greatest global achievements for public health. Since the introduction of the first vaccines, vaccination programs have contributed to a substantial decline in both mortality and morbidity of many previously lethal infectious diseases around the globe. However, high and sustained vaccine uptake is necessary for these efforts to remain successful. Beyond the direct protection provided for vaccinated individuals, high vaccine coverage also induces indirect protection against vaccinepreventable diseases (VPD) at a population level through herd immunity. Yet despite consensus on the public health benefits of vaccination, recent reports of clustered outbreaks and the resurgence of VPDs in underor nonimmunized groups highlight the ongoing challenges. The concept of vaccine hesitancy represents a significant conceptual shift away from the traditional dichotomy of accept or reject, of proor antivaccine. Defined by the World Health Organization’s (WHO) SAGE Working Group as “the delay in acceptance or refusal of vaccination despite availability of vaccination services,” vaccine hesitancy is “complex and context specific, varying across time, place and vaccines. It is influenced by factors such as complacency, convenience and confidence.” Vaccine hesitancy highlights the wide spectrum of vaccination beliefs, attitudes and behaviours of a large heterogeneous group of individuals situated between the 2 end points of the continuum (see Figure 1). For example, vaccine-hesitant individuals may refuse some vaccines but accept or delay others; some may accept a vaccine but remain concerned with their decision; and others may even personally refuse all vaccines but remain supportive of vaccinations more broadly. While vaccine hesitancy is not always the root cause of underor nonimmunization, it is listed in the top 10 threats to global health for 2019 by the WHO and remains an important contributor to suboptimal vaccine coverage across many jurisdictions. A large body of interdisciplinary research has explored the factors and determinants that shape vaccine-hesitant beliefs, attitudes and behaviours. From a practice perspective, 3 observations are particularly important:\",\"PeriodicalId\":46612,\"journal\":{\"name\":\"Canadian Pharmacists Journal\",\"volume\":\"152 1\",\"pages\":\"391 - 394\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2019-10-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1177/1715163519878745\",\"citationCount\":\"8\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Canadian Pharmacists Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/1715163519878745\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Pharmacists Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/1715163519878745","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 8

摘要

毫无疑问,疫苗接种可被视为公共卫生领域最伟大的全球成就之一。自从第一批疫苗问世以来,疫苗接种项目大大降低了全球许多以前致命的传染病的死亡率和发病率。然而,要使这些努力保持成功,高水平和持续的疫苗接种率是必要的。除了为接种疫苗的个人提供直接保护外,高疫苗覆盖率还通过群体免疫在人群水平上对疫苗可预防疾病(VPD)产生间接保护。然而,尽管对疫苗接种的公共卫生益处达成共识,但最近关于聚集性暴发和在未接种疫苗或未接种疫苗的人群中再次出现vpd的报告突出了持续的挑战。疫苗犹豫的概念代表了从传统的接受或拒绝、原抗疫苗二分法的重大概念转变。世界卫生组织(世卫组织)SAGE工作组将疫苗犹豫定义为“尽管有疫苗接种服务,但仍延迟接受或拒绝疫苗接种”,“疫苗犹豫是复杂的,因时间、地点和疫苗而异。”它受到自满、便利和自信等因素的影响。”疫苗犹豫突出了位于连续体的两个端点之间的大量异质群体的疫苗接种信念、态度和行为的广泛范围(见图1)。例如,疫苗犹豫的个人可能拒绝某些疫苗,但接受或推迟其他疫苗;有些人可能会接受疫苗,但仍对自己的决定感到担忧;其他人甚至可能个人拒绝所有疫苗,但仍然支持更广泛的疫苗接种。虽然疫苗犹豫并不总是免疫不足或未免疫的根本原因,但它被世卫组织列为2019年全球健康的十大威胁之一,并且仍然是许多司法管辖区疫苗覆盖率不理想的重要因素。大量跨学科研究探索了形成对疫苗犹豫不决的信念、态度和行为的因素和决定因素。从实践的角度来看,有三点特别重要:
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Vaccine hesitancy: Moving practice beyond binary vaccination outcomes in community pharmacy
Introduction Unequivocally, vaccinations can be considered one of the greatest global achievements for public health. Since the introduction of the first vaccines, vaccination programs have contributed to a substantial decline in both mortality and morbidity of many previously lethal infectious diseases around the globe. However, high and sustained vaccine uptake is necessary for these efforts to remain successful. Beyond the direct protection provided for vaccinated individuals, high vaccine coverage also induces indirect protection against vaccinepreventable diseases (VPD) at a population level through herd immunity. Yet despite consensus on the public health benefits of vaccination, recent reports of clustered outbreaks and the resurgence of VPDs in underor nonimmunized groups highlight the ongoing challenges. The concept of vaccine hesitancy represents a significant conceptual shift away from the traditional dichotomy of accept or reject, of proor antivaccine. Defined by the World Health Organization’s (WHO) SAGE Working Group as “the delay in acceptance or refusal of vaccination despite availability of vaccination services,” vaccine hesitancy is “complex and context specific, varying across time, place and vaccines. It is influenced by factors such as complacency, convenience and confidence.” Vaccine hesitancy highlights the wide spectrum of vaccination beliefs, attitudes and behaviours of a large heterogeneous group of individuals situated between the 2 end points of the continuum (see Figure 1). For example, vaccine-hesitant individuals may refuse some vaccines but accept or delay others; some may accept a vaccine but remain concerned with their decision; and others may even personally refuse all vaccines but remain supportive of vaccinations more broadly. While vaccine hesitancy is not always the root cause of underor nonimmunization, it is listed in the top 10 threats to global health for 2019 by the WHO and remains an important contributor to suboptimal vaccine coverage across many jurisdictions. A large body of interdisciplinary research has explored the factors and determinants that shape vaccine-hesitant beliefs, attitudes and behaviours. From a practice perspective, 3 observations are particularly important:
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Canadian Pharmacists Journal
Canadian Pharmacists Journal PHARMACOLOGY & PHARMACY-
CiteScore
2.50
自引率
26.70%
发文量
43
期刊介绍: Established in 1868, the Canadian Pharmacists Journal is the oldest continuously published periodical in Canada. Our mission is to enhance patient care through advancement of pharmacy practice, with continuing professional development, peer-reviewed research, and advocacy. Our vision is to become the foremost journal for pharmacy practice and research.
期刊最新文献
The role of Alberta pharmacists working in opioid use disorder and their potential to prescribe buprenorphine-naloxone: A qualitative study. Opportunities and challenges associated with the launch of nirmatrelvir/ritonavir (Paxlovid) in British Columbia during the COVID-19 pandemic: A qualitative study to explore community pharmacists' perspectives. Lyme disease chemoprophylaxis prescribing before and after pharmacist prescriptive authority in Nova Scotia. Enabling pharmacist prescribing: Lessons learned in Nova Scotia using behaviour change theory. British Columbia community pharmacy during COVID-19: Describing the patient experience via Google reviews.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1